Long-Term Changes in HbA1c According to Blood Glucose Control Status During the First 3 Months After Visiting a Tertiary University Hospital

다국어 초록 (Multilingual Abstract)

Background: We evaluated patients visiting a tertiary university hospital due to a diagnosis of diabetes with a goal of achieving blood glucose control and evaluated blood glucose persistence over 7 years according to the change in blood glucose evident at 3 months after the first visit.
Methods: Patients treated from 2009 to 2013 were categorized into four groups according to the change in HbA1c levels during the first 3 months of follow-up (Best_group, ≥ 1.6% decrease; Better_group, 0.5–1.5% decrease; Neutral_group, maintained at −0.4% to +0.4%; Worse_group, ≥ 0.5% increase). Each patient’s blood glucose control status was then monitored for 7 years. The incidence of stroke and acute coronary syndrome during this period was confirmed.
Results: Overall, 9,776 patients were included. HbA1c values were lower in the Best_group than in the other groups at all time points (all P < 0.001). The rate of reaching targets of < 6.5% or < 7.0% HbA1c decreased over time; the rate at which the estimated glomerular filtration rate decreased to < 30 or < 60 mL/min/1.73m2 increased over time (all trends, P < 0.01).
Conclusion: Blood glucose control status in the first 3 months after initiating hospital care enabled estimation of the patient’s glycemic control status for the next 7 years. In cases with poor initial blood glucose control, a new or more active method of blood glucose control should be sought.

참고문헌 (Reference)

1 임동준 ; 권혁상 ; 김희수 ; 이진희 ; 고승현 ; 이정민 ; 김성래 ; 이원철 ; 손현식 ; 차봉연 ; 이광우 ; 손호영 ; 강성구 ; 윤건호, "서울？경기 지역의 의료기관별로 관찰한 당뇨병 환자의 임상적 특징" 대한내과학회 71 (71): 173-181, 2006

2 Park J, "Validation of diagnostic codes of major clinical outcomes in a National Health Insurance database" 20 (20): 5-, 2019

3 박태환 ; 최재철, "Validation of Stroke and Trombolytic Terapy in Korean National Health Insurance Claim Data" 대한신경과학회 12 (12): 42-48, 2016

4 경대성 ; 김헌성, "Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research" 한국지질동맥경화학회 11 (11): 103-110, 2022

5 Laiteerapong N, "The legacy effect in type 2 diabetes:impact of early glycemic control on future complications (the diabetes & aging study)" 42 (42): 416-426, 2019

6 Folz R, "The legacy effect in diabetes : are there long-term benefits?" 64 (64): 2131-2137, 2021

7 Nathan DM, "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus" 329 (329): 977-986, 1993

8 Kim KJ, "Success factors in hospital network performance : evidence from Korea" 20 (20): 141-152, 2007

9 Kang Dong Yoon ; Kim Hyunah ; Ko SooJeong ; Kim HyungMin ; Shinn Jiwon ; Kang Min-Gyu ; Byeon Sun-ju ; Choi Jeong-Hee ; Shin Soo-Yong ; Kim Hun-Sung, "Sodium-Glucose Cotransporter-2 Inhibitor-Related Diabetic Ketoacidosis: Accuracy Verification of Operational Definition" 대한의학회 37 (37): 1-12, 2022

10 김헌성 ; 이수현 ; 김주한, "Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records" 대한의학회 33 (33): 1-7, 2018

11 김헌성 ; 김주한, "Proceed with Caution When Using Real World Data and Real World Evidence" 대한의학회 34 (34): 1-5, 2019

12 Balkau B, "Predictors of HbA1c over 4years in people with type 2 diabetes starting insulin therapies : the CREDIT study" 108 (108): 432-440, 2015

13 김헌성 ; 김대진 ; 윤건호, "Medical Big Data Is Not Yet Available - Why We Need Realism Rather Than Exaggeration" 대한내분비학회 34 (34): 349-354, 2019

14 Murray P, "Legacy effects from DCCT and UKPDS : what they mean and implications for future diabetes trials" 12 (12): 432-439, 2010

15 UK Prospective Diabetes Study (UKPDS) Group, "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)" 352 (352): 837-853, 1998

16 Patel A, "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes" 358 (358): 2560-2572, 2008

17 Cho NH, "IDF Diabetes Atlas : global estimates of diabetes prevalence for 2017 and projections for 2045" 138 : 271-281, 2018

18 Petersohn I, "Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition" 157 : 107843-, 2019

19 Zoungas S, "Follow-up of blood-pressure lowering and glucose control in type 2 diabetes" 371 (371): 1392-1406, 2014

20 Ko S, "Estimation of sodium-glucose cotransporter 2inhibitor-related genital and urinary tract infections via electronic medical record-based common data model" 46 (46): 975-983, 2021

21 Li D, "Durability of glycaemic control in type 2 diabetes : a systematic review and meta-analysis for its association with body weight changes" 23 (23): 208-217, 2021

22 Chatterjee S, "Diabetes structured self-management education programmes : a narrative review and current innovations" 6 (6): 130-142, 2018

23 Lenzen M, "Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease : a report from the Euro Heart Survey on diabetes and the heart" 27 (27): 2969-2974, 2006

24 정찬희 ; 손장원 ; 강신애 ; 김원준 ; 김헌성 ; 김혜순 ; 서미혜 ; 신혜정 ; 이성수 ; 정수진 ; 조용인 ; 한승진 ; 장향미 ; 노미라 ; 이신비 ; 구미현 ; 유빈 ; 문정화 ; 이혜영 ; 윤재승 ; 김선영 ; 김성래 ; 정인경 ; 목지오 ; 윤건호, "Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status" 대한당뇨병학회 45 (45): 1-10, 2021

25 신수용 ; 김헌성, "Data Pseudonymization in a Range That Does Not Affect Data Quality: Correlation with the Degree of Participation of Clinicians" 대한의학회 36 (36): 1-11, 2021

26 서다혜 ; 강신애 ; 이용호 ; 하정윤 ; 박종숙 ; 이병완 ; 강은석 ; 안철우 ; 차봉수, "Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea" 대한내분비학회 34 (34): 282-290, 2019